Composition
- Active ingredients
- LENVATINIB MESYLATE EQ 4MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- LENVATINIB MESYLATE EQ 4MG BASE · CapsuleThis page
- LENVATINIB MESYLATE EQ 10MG BASE · CapsuleNDA206947-002 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA206947.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Lenvima
- Active substance
- lenvatinib mesylate
- Route
- Oral
- Dosage form
- Capsule
- Applicant
- Eisai Inc
- Status
- Prescription
- FDA approval
- 13 Feb 2015
- Application
- NDA206947-001